These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 32884036)

  • 21. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
    De Nardi P; Guarneri G; Canevari C; Tamburini A; Slim N; Passoni P; Rosati R
    Colorectal Dis; 2019 Sep; 21(9):1017-1024. PubMed ID: 31077550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients.
    Franco P; Arcadipane F; Ragona R; Mistrangelo M; Cassoni P; Munoz F; Rondi N; Morino M; Racca P; Ricardi U
    Br J Radiol; 2016; 89(1060):20150832. PubMed ID: 26838953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer.
    Joseph K; Nijjar Y; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Ghosh S; Syme A; Nijjar T; Mulder K; Doll C; Wong C; Field C
    Radiother Oncol; 2015 Nov; 117(2):234-9. PubMed ID: 26306677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
    Jones M; Hruby G; Solomon M; Rutherford N; Martin J
    Ann Surg Oncol; 2015 Oct; 22(11):3574-81. PubMed ID: 25652048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience of SIB-IMRT in anal cancer and selective literature review.
    Janssen S; Glanzmann C; Bauerfeind P; Stieb S; Studer G; Brown M; Riesterer O
    Radiat Oncol; 2014 Sep; 9():199. PubMed ID: 25199879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
    Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma.
    Blinde SE; Schasfoort R; Mens JW; Verhoef C; Olofsen M; Nuyttens JJ
    Dis Colon Rectum; 2014 May; 57(5):578-84. PubMed ID: 24819097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.
    Call JA; Prendergast BM; Jensen LG; Ord CB; Goodman KA; Jacob R; Mell LK; Thomas CR; Jabbour SK; Miller RC
    Am J Clin Oncol; 2016 Feb; 39(1):8-12. PubMed ID: 24401669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis.
    Dasgupta T; Rothenstein D; Chou JF; Zhang Z; Wright JL; Saltz LB; Temple LK; Paty PB; Weiser MR; Guillem JG; Nash GM; Goodman KA
    Radiother Oncol; 2013 May; 107(2):189-94. PubMed ID: 23692961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
    James RD; Glynne-Jones R; Meadows HM; Cunningham D; Myint AS; Saunders MP; Maughan T; McDonald A; Essapen S; Leslie M; Falk S; Wilson C; Gollins S; Begum R; Ledermann J; Kadalayil L; Sebag-Montefiore D
    Lancet Oncol; 2013 May; 14(6):516-24. PubMed ID: 23578724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literature.
    Mistrangelo DM; Bellò M; Cassoni P; Milanesi E; Racca P; Munoz F; Fora G; Rondi N; Gilbo N; Senetta R; Ricardi U; Morino M
    Br J Cancer; 2013 Feb; 108(3):527-32. PubMed ID: 23329231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approach to anal cancer: individualized therapy based on sentinel lymph node biopsy.
    De Nardi P; Carvello M; Staudacher C
    World J Gastroenterol; 2012 Nov; 18(44):6349-56. PubMed ID: 23197880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.
    Kachnic LA; Winter K; Myerson RJ; Goodyear MD; Willins J; Esthappan J; Haddock MG; Rotman M; Parikh PJ; Safran H; Willett CG
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):27-33. PubMed ID: 23154075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of positron emission tomography-computed tomography in the management of anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
    Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study).
    Ortholan C; Resbeut M; Hannoun-Levi JM; Teissier E; Gerard JP; Ronchin P; Zaccariotto A; Minsat M; Benezery K; François E; Salem N; Ellis S; Azria D; Champetier C; Gross E; Cowen D
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1988-95. PubMed ID: 21570207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.
    Bazan JG; Hara W; Hsu A; Kunz PA; Ford J; Fisher GA; Welton ML; Shelton A; Kapp DS; Koong AC; Goodman KA; Chang DT
    Cancer; 2011 Aug; 117(15):3342-51. PubMed ID: 21287530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel node biopsy in squamous-cell carcinoma of the anal canal.
    De Nardi P; Carvello M; Canevari C; Passoni P; Staudacher C
    Ann Surg Oncol; 2011 Feb; 18(2):365-70. PubMed ID: 20803079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
    Pepek JM; Willett CG; Wu QJ; Yoo S; Clough RW; Czito BG
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1413-9. PubMed ID: 20231064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.